Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-97-000432
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
11
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 325497
2 EXHIBIT 10.150 EX-10.150 75659
3 EXHIBIT 10.155 EX-10.155 5277
4 EXHIBIT 10.156 EX-10.156 5030
5 EXHIBIT 10.157 EX-10.157 82520
6 EXHIBIT 10.158 EX-10.158 263661
7 EXHIBIT 10.159 EX-10.159 11977
8 EXHIBIT 10.160 EX-10.160 8450
9 EXHIBIT 21.1 EX-21.1 418
10 EXHIBIT 23.1 EX-23.1 704
11 EXHIBIT 27.1 EX-27.1 2232
  Complete submission text file 0000936392-97-000432.txt   783788
Mailing Address 9393 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DR STE 100 SAN DIEGO CA 92121 6195353900
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 97568828
SIC: 2834 Pharmaceutical Preparations